Pharmacology and the Treatment of Complicated Skin and Skin-Structure Infections

被引：19
|
作者：
Chambers, Henry F. [1 ,2 ]
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] San Francisco Gen Hosp, Div Infect Dis, San Francisco, CA 94110 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 370卷 / 23期
关键词：
D O I：
10.1056/NEJMe1405078
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2238 / 2239
页数：2
相关论文
共 50 条
  • [31] Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections
    Itani, Kamal M. F.
    Akhras, Kasem S.
    Stellhorn, Robert
    Quintana, Alvaro
    Budd, David
    Merchant, Sanjay
    PHARMACOECONOMICS, 2009, 27 (05) : 421 - 430
  • [32] Linezolid for the treatment of complicated skin and skin structure infections in children
    Yogev, R
    Patterson, LE
    Kaplan, SL
    Adler, S
    Morfin, MR
    Martin, A
    Edge-Padbury, B
    Naberhuis-Stehouwer, S
    Bruss, JB
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) : S172 - S175
  • [33] Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections
    Nawar, Tamara
    Kanafani, Zeina A.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (07) : 825 - 833
  • [34] Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections
    Carena, Alberto A.
    Stryjewski, Martin E.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (06) : 577 - 592
  • [35] CLARITHROMYCIN IN THE TREATMENT OF SKIN AND SKIN-STRUCTURE INFECTIONS - 2 MULTICENTER CLINICAL-STUDIES
    PARISH, LC
    BRANDON, M
    CULLEN, S
    ELLIOT, ST
    FARBER, GA
    FELICETTA, J
    FREILICH, IW
    GILDERMAN, L
    GINSBERG, D
    GOLLAPUDI, GM
    GRECO, T
    GRIFFIN, EI
    HESKEL, NS
    HOLMBURG, CE
    HOWELL, JP
    LISK, S
    MATHER, S
    MENTER, A
    MOSELEY, JC
    MIKELL, OL
    MILIKAN, LE
    MILLER, DJ
    RIST, T
    ROSAS, SL
    ROTH, H
    SCHOCH, EP
    SHAVEN, J
    SNYDER, JS
    STEWART, AA
    SWINEHART, JM
    TAYLOR, M
    TURNER, SV
    WAXMAN, M
    ZELLNER, S
    ZONE, J
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (07) : 528 - 532
  • [36] TREATMENT OF POLYMICROBIAL GYNECOLOGIC AND SKIN AND SKIN-STRUCTURE INFECTIONS - WORLDWIDE CLINICAL-TRIALS
    SANDERS, CV
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1995, 4 : S26 - S32
  • [37] Complicated Skin and Skin-Structure Infections and Catheter-Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study
    Wilcox, Mark H.
    Tack, Kenneth J.
    Bouza, Emilio
    Herr, Daniel L.
    Ruf, Bernhard R.
    Ijzerman, M. Marian
    Croos-Dabrera, Rodney V.
    Kunkel, Mark J.
    Knirsch, Charles
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (02) : 203 - 212
  • [38] CEFADROXIL IN SKIN AND SKIN-STRUCTURE FOOT INFECTIONS - A RETROSPECTIVE REVIEW
    YU, GV
    NOVICKI, DC
    ADVANCES IN THERAPY, 1995, 12 (01) : 1 - 10
  • [39] A COMPARISON OF AMPICILLIN-SULBACTAM AND CEFOXITIN IN THE TREATMENT OF BACTERIAL SKIN AND SKIN-STRUCTURE INFECTIONS
    WEIGELT, JA
    ADVANCES IN THERAPY, 1994, 11 (04) : 183 - 191
  • [40] Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections
    Edelsberg, John
    Berger, Ariel
    Weber, David J.
    Mallick, Rajiv
    Kuznik, Andreas
    Oster, Gerry
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (02): : 160 - 169
12345